Table 5 Results of meta-analysis in different statins groups in Western and Asian
Group | Included arms (and case) | Pooled SMD (95% CI,p) | Heterogeneity test | Sensitivity analyses | Egger’s test | |||
|---|---|---|---|---|---|---|---|---|
χ2test (p) | I 2 | Lower SMD (95% CI) | Upper SMD (95% CI) | |||||
Western | Rosuvastatin | 2(869) | −0.158(−0.253 ~ −0.064, 0.001) | 0.18(0.672) | 0 | −0.142 (−0.263 ~ −0.020) Without 2006 ASTEROID Ros | −0.183 (−0.332 ~ −0.035) Without 2011 SATURN Ros | 0.000 |
Atorvastatin | 2(772) | −0.062(−0.162 ~ 0.038, 0.225) | 0.62(0.432) | 0 |  |  | 0.000 | |
Pravastatin | 1(249) | 0.045(−0.131 ~ 0.221, 0.616) |  |  |  |  |  | |
Simvastatin | 1(40) | −0.133(−0.572 ~ 0.306, 0.552) |  |  |  |  |  | |
Asian | Rosuvastatin | 3(304) | −0.172(−0.331 ~ −0.012, 0.035) | 0.17(0.917) | 0 | −0.143 (−0.352 ~ 0.066) Without 2012 ARTMAP Ros | −0.189 (−0.397 ~ 0.019) Without 2009 COSMOS Ros | 0.660 |
Atorvastatin | 6(366) | −0.185(−0.330 ~ −0.040, 0.013) | 1.94(0.858) | 0 | −0.113 (−0.292 ~ 0.068) Without 2009 JAPAN-ACS Ato | −0.230 (−0.417 ~ −0.044) Without 2012 ARTMAP Ato | 0.456 | |
Pravastatin | 2(70) | −0.197(−0.529 ~ 0.135, 0.245) | 0.26(0.608) | 0 |  |  |  | |
Pitavastatin | 1(125) | −0.304(−0.553 ~ −0.055, 0.017) |  |  |  |  |  | |
Fluvastatin | 1(40) | −0.169(−0.608 ~ 0.270, 0.450) |  |  |  |  |  | |
Simvastatin | 1(50) | −0.074(−0.467 ~ 0.318, 0.710) |  |  |  |  |  | |